1-11 of 11
Nolan Wages
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CUX1 mut Acute Myeloid Leukemia As a Distinct Biological Entity: An Analysis of Clinical Outcomes and Implications

Ian Bouligny, Graeme Murray, Thuy Ho, Juhi Gor, Kyle Zacholski, Nolan Wages, Steven Grant, Keri Maher
Journal: Blood
Blood (2023) 142 (Supplement 1): 5978.
https://doi.org/10.1182/blood-2023-189407
Published: 2023
Journal Articles

Comparison of Response and Survival with Chemotherapy and Targeted Therapies between IDH mut Isoforms in Acute Myeloid Leukemia

Ian Bouligny, Graeme Murray, Thuy Ho, Juhi Gor, Kyle Zacholski, Nolan Wages, Steven Grant, Keri Maher
Journal: Blood
Blood (2023) 142 (Supplement 1): 6010.
https://doi.org/10.1182/blood-2023-188362
Published: 2023
Journal Articles

FLT3 Inhibitors in Combination with FLAG-IDA in Relapsed or Refractory Acute Myeloid Leukemia

Ian Bouligny, Graeme Murray, Thuy Ho, Juhi Gor, Kyle Zacholski, Nolan Wages, Steven Grant, Keri Maher
Journal: Blood
Blood (2023) 142 (Supplement 1): 5920.
https://doi.org/10.1182/blood-2023-188333
Published: 2023
Journal Articles

The Molecular Landscape of Acute Myeloid Leukemia with Trisomy 8: A Comprehensive Cancer Center Analysis of 627 Patients

Ian Bouligny, Graeme Murray, Thuy Ho, Juhi Gor, Kyle Zacholski, Nolan Wages, Steven Grant, Keri Maher
Journal: Blood
Blood (2023) 142 (Supplement 1): 6053.
https://doi.org/10.1182/blood-2023-189260
Published: 2023
Journal Articles

Revisiting Ratify: Daunorubicin 60 Mg/m 2 Vs 90 Mg/m 2 in Previously Untreated FLT3 mut Acute Myeloid Leukemia

Ian Bouligny, Graeme Murray, Thuy Ho, Juhi Gor, Kyle Zacholski, Nolan Wages, Steven Grant, Keri Maher
Journal: Blood
Blood (2023) 142 (Supplement 1): 5912.
https://doi.org/10.1182/blood-2023-189138
Published: 2023
Journal Articles

The Impact of Delayed Venetoclax Initiation on Overall Survival in Acute Myeloid Leukemia

Ian Bouligny, Graeme Murray, Thuy Ho, Juhi Gor, Kyle Zacholski, Nolan Wages, Steven Grant, Keri Maher
Journal: Blood
Blood (2023) 142 (Supplement 1): 4233.
https://doi.org/10.1182/blood-2023-188249
Published: 2023
Journal Articles

CPX-351 Versus FLAG-IDA with or without Venetoclax in Previously Untreated and Relapsed or Refractory Acute Myeloid Leukemia

Ian Bouligny, Graeme Murray, Thuy Ho, Juhi Gor, Kyle Zacholski, Nolan Wages, Steven Grant, Keri Maher
Journal: Blood
Blood (2023) 142 (Supplement 1): 4269.
https://doi.org/10.1182/blood-2023-189184
Published: 2023
Journal Articles

First-Line Venetoclax and a Hypomethylating Agent or Conventional Chemotherapy in Older Adults with IDH -Mutated AML

Ian Bouligny, Graeme Murray, Thuy Ho, Juhi Gor, Kyle Zacholski, Nolan Wages, Steven Grant, Keri Maher
Journal: Blood
Blood (2023) 142 (Supplement 1): 1488.
https://doi.org/10.1182/blood-2023-188400
Published: 2023
Journal Articles

Validation of the Charlson Comorbidity Index Model in Acute Myeloid Leukemia Treated with a Hypomethylating Agent and Venetoclax

Ian Bouligny, Graeme Murray, Thuy Ho, Juhi Gor, Kyle Zacholski, Nolan Wages, Steven Grant, Keri Maher
Journal: Blood
Blood (2023) 142 (Supplement 1): 5093.
https://doi.org/10.1182/blood-2023-189322
Published: 2023
Journal Articles

Initial Report of a Multi-Institution Phase I/Ib Study of Ibrutinib with Venetoclax in Relapsed or Refractory Mantle Cell Lymphoma

Craig A. Portell, MD, Robert W Chen, MD, Nolan Wages, PhD, Jonathon B. Cohen, MD, Michael J. Weber, PhD, Gina Petroni, PhD, Brad S. Kahl, MD, Michael E Williams, MD
Journal: Blood
Blood (2016) 128 (22): 2958.
https://doi.org/10.1182/blood.V128.22.2958.2958
Published: 2016
Journal Articles

Fluoroquinolone Prophylaxis Following Induction Chemotherapy in Patients with Acute Leukemia: Patterns of Infection

Patrick Reagan, MD, Tri Le, MD, Michael E. Williams, M.D., Nolan Wages, PhD
Journal: Blood
Blood (2012) 120 (21): 2077.
https://doi.org/10.1182/blood.V120.21.2077.2077
Published: 2012